menu
    • menu

    Company profile for Celon Pharma

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life. One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective dru...
    Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life. One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Celon PharmaPoland Flag
    Country
    Country
    Poland
    Address
    Address
    Ogrodowa 2A 05-092 Łomianki / Kiełpin
    Telephone
    Telephone
    +48 22 751 59 33
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://celonpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celon-pharma-s-a/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Clears Celon Pharma's Schizophrenia Drug For Phase 3 Trial
    FDA Clears Celon Pharma's Schizophrenia Drug For Phase 3 Trial

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/08/3163145/0/en/FDA-Clears-Celon-Pharma-s-Schizophrenia-Drug-for-Phase-3-Trial.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share
    Strong Ph2 Data For PDE10A Inhibitor CPL36 In Parkinson’s Dyskinesia
    Strong Ph2 Data For PDE10A Inhibitor CPL36 In Parkinson’s Dyskinesia

    04 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/04/3036951/0/en/Strong-Proof-of-Concept-Data-from-Phase-2-Trial-of-PDE10A-Inhibitor-CPL-36-a-Novel-Once-Daily-Treatment-of-Levodopa-Induced-Dyskinesia-in-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    04 Mar 2025
    Share Share
    Poland's Celon Pharma sees schizophrenia drug as 'billion-dollar' product
    Poland's Celon Pharma sees schizophrenia drug as 'billion-dollar' product

    10 Jul 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/polands-celon-pharma-sees-schizophrenia-drug-billion-dollar-product-2024-07-10/

    REUTERS
    10 Jul 2024
    Share Share
    Celon Pharma Announces Results Of Phase II Clinical Trial For CPL’ 116 In RA
    Celon Pharma Announces Results Of Phase II Clinical Trial For CPL’ 116 In RA

    17 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/17/2900003/0/en/Celon-Pharma-Announces-Results-of-Phase-II-clinical-trial-for-CPL-116-a-JAK-ROCK-dual-inhibitor-in-the-treatment-of-Rheumatoid-Arthritis-RA.html

    GLOBENEWSWIRE
    17 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search